5 Best Low Price Pharma Stocks To Buy Now

Page 5 of 5

1. Teva Pharmaceutical Industries Limited (NYSE:TEVA)

Number of Hedge Fund Holders: 35

Share Price as of October 17: $7.95

Teva Pharmaceutical Industries Limited (NYSE:TEVA) is an Israel-based pharmaceutical company that develops, manufactures, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. On October 7, Teva Pharmaceutical Industries Limited (NYSE:TEVA), the biggest supplier of the generic version of Adderall, announced that it expects shortages of the medication to continue for another two to three months. Teva Pharmaceutical Industries Limited (NYSE:TEVA) is one of the leading low price pharma stocks. 

On August 5, BofA analyst Jason Gerberry upgraded Teva Pharmaceutical Industries Limited (NYSE:TEVA) to Buy from Neutral with a price target of $13, up from $10. The company is making significant progress towards wrapping up its litigation overhangs and concluding opioid settlements, which should be enough to put Teva Pharmaceutical Industries Limited (NYSE:TEVA) on the path to EBITDA growth, the analyst told investors in a research note. He added that Teva Pharmaceutical Industries Limited (NYSE:TEVA) offers a “solid” new product cycle pipeline in 2023-2024.

According to Insider Monkey’s data, 35 hedge funds were long Teva Pharmaceutical Industries Limited (NYSE:TEVA) at the end of Q2 2022, up from 26 funds in the prior quarter. David Abrams’ Abrams Capital Management is the largest stakeholder of the company, with more than 24 million shares worth nearly $181 million.

You can also take a look at Best Asian Stocks To Buy and 15 Best Gambling Stocks To Buy

Page 5 of 5